Sony Pictures has picked up worldwide rights to "The Surgeon," a high-concept action vehicle built around Michelle Yeoh, the studio confirmed Tuesday. The deal, hammered out over the past several weeks, hands Sony one of the most sought-after packages of the fall, pairing an Oscar-winning star with a premise that backers describe as a propulsive, character-driven thriller. No release date has been set, and studio executives declined to discuss budget or production timelines.

The project arrives at a moment when Yeoh's commercial standing has rarely been stronger. Since her Academy Award win for "Everything Everywhere All at Once," she has become one of the few performers in the industry whose name alone can anchor a global marketing campaign. Sony's acquisition signals that the studio intends to build "The Surgeon" as a theatrical event rather than a streaming title, according to two people familiar with the negotiations who were not authorized to speak publicly.

A Familiar Title, A Very Different Film

Executives were quick to note that the new project bears no connection to the 1995 horror feature of the same name. That earlier "The Surgeon," directed by Carl Schenkel and running 99 minutes, followed Dr. Julian Mater, a physician whose license is revoked after he conducts cellular-regeneration experiments on dying patients. Years later, he returns to the hospital that condemned his work and resumes his grisly research. Released on Jan. 13, 1995, in English, the film starred Isabel Glasser as Dr. Theresa McCann, James Remar as Dr. Benjamin Hendricks, Sean Haberle as Dr. Julian Matar, Peter Boyle as Lt. McEllwaine, Malcolm McDowell as Dr. Stein, Charles Dance as Dr. Ed Mittlesbay, Beverly Todd as Nurse Burns, and Charles Bailey-Gates as Sgt. Ross.

That version, a horror and science-fiction hybrid, holds a 5.065 rating out of 10 on TMDb - a middling score that has done little to dim the cult curiosity surrounding it. Sony's newly acquired package is an entirely separate property, and insiders stressed that any shared title is coincidental rather than a remake play.

Why Sony Moved Fast

The pitch, according to people who heard it, centers on a surgeon drawn into a conspiracy that forces her to rely on the skills she left behind. It is designed as a star showcase, with set pieces calibrated to Yeoh's well-documented facility for hand-to-hand combat and physical performance. Several buyers circled the material before Sony closed the deal, one of the people said.

For Sony, the acquisition fits a broader strategy of filling its calendar with mid-budget, star-driven genre films that can travel internationally. The studio has had success in recent years with action titles that lean on a single marquee name, and Yeoh's appeal in Asian markets - she has worked across Hong Kong, Hollywood, and beyond for four decades - makes her an unusually valuable asset for a global rollout.

A Star Still at Peak Demand

Yeoh's schedule has become one of the most closely watched in town. She has alternated between franchise work, prestige dramas, and television, and her dealmaking has grown more selective since the Oscar win. Representatives for the actress did not respond to requests for comment by press time, and it remains unclear when "The Surgeon" would shoot relative to her existing commitments.

The project also reflects a persistent appetite among studios for medical and procedural backdrops as scaffolding for action. Hospitals, with their locked wards, labyrinthine corridors, and life-or-death stakes, offer filmmakers a ready-made pressure cooker - a fact not lost on the producers behind the 1995 film, whose mad-doctor premise mined similar territory.

What Comes Next

Sony has not announced a director, writers, or additional cast. The studio is expected to move quickly given Yeoh's availability window, though no start date has been firmed up. Distribution plans beyond the domestic market have yet to be detailed.

For now, the acquisition stands as one of the fall's more notable package deals - a reminder that in the current marketplace, a single star with proven global reach can still move a project off the shelf and into a studio's priority column. Whether "The Surgeon" becomes a franchise starter or a one-off thriller will depend on a script that, as of Tuesday, remained under wraps.

Sony declined to comment beyond confirming the acquisition.

Source: Hollywood Reporter